Tatva Chintan Pharma Chem Ltd Q1 FY2025 consolidated PAT slides to Rs. 5.20 crores

Tatva Chintan Pharma Chem Ltd has reported Consolidated financial results for the period ended June 30, 2024.

Financial Results (Q1 FY2025) - QoQ Comparison

The company has reported total income of Rs. 106.637 crores during the period ended June 30, 2024 as compared to Rs. 102.794 crores during the period ended March 31, 2024.

The company has posted net profit / (loss) of Rs. 5.209 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs. 9.614 crores for the period ended March 31, 2024.

The company has reported EPS of Rs. 2.23 for the period ended June 30, 2024 as compared to Rs. 4.11 for the period ended March 31, 2024.

Financials	Q1 FY2025	Q4 FY2024	% Change
Total Income	₹106.637 crs	₹102.794 crs	3.74%
Net Profit	₹5.209 crs	₹9.614 crs	-45.82%
EPS	₹2.23	₹4.11	-45.74%

Financial Results (Q1 FY2025) - YoY Comparison

The company has reported total income of Rs.106.637 crores during the period ended June 30, 2024 as compared to Rs.115.379 crores during the period ended June 30, 2023.

The company has posted net profit / (loss) of Rs.5.209 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs.9.504 crores for the period ended June 30, 2023.

The company has reported EPS of Rs.2.23 for the period ended June 30, 2024 as compared to Rs.4.29 for the period ended June 30, 2023.

Financials	Q1 FY2025	Q1 FY2024	% Change
Total Income	₹106.637 crs	₹115.379 crs	-7.58%
Net Profit	₹5.209 crs	₹9.504 crs	-45.19%
EPS	₹2.23	₹4.29	-48.02%

Shares of Tatva Chintan Pharma Chem Ltd was last trading in BSE at Rs. 1082.15 as compared to the previous close of Rs. 1076.80. The total number of shares traded during the day was 3361 in over 764 trades.

The stock hit an intraday high of Rs. 1112.15 and intraday low of 1035.00. The net turnover during the day was Rs. 3595307.00.

Source : Equity Bulls

Keywords

TatvaChintanPharmaChem Q1FY25 FY2025 Q1FY2025 ResultUpdate